LOTTE BIOLOGICS establishes contract manufacturing partnership with a leading U.S. Biopharmaceutical Company

Contributed by: PR Newswire

Images

PR Newswire associated0

Tags

LOTTE-U.S.-Contract

More Like This

PR Newswire associated0

LOTTE BIOLOGICS Signs Antibody Manufacturing Contract with Ottimo Pharma

PR Newswire associated0

LOTTE Holdings establishes a new Healthcare and Biopharmaceutical Corporate Venture Capital

PR Newswire associated0

LOTTE BIOLOGICS Holds Groundbreaking for Songdo Bio Campus

Business Wire logo

Following a Successful FDA Inspection, KBI Biopharma Extends and Expands Commercial Contract with Leading Global Pharmaceutical Company

Business Wire associated0

Biocytogen Enters into Agreement with Merck, KGaA, Darmstadt, Germany to Advance Antibody-Conjugated Lipid-Based Delivery Solutions

From left: Jeffrey Chen, Vice President, BD (Becton Dickinson) Greater Asia; Yoo Young-ho, President, Celltrion Pharm; and Jason Hwang, Country General Manager, BD Korea, at the trilateral agreement signing ceremony.

Celltrion Pharm Signs Strategic Trilateral Agreement with Becton Dickinson and BD Korea to Accelerate Global PFS CMO Business

PR Newswire associated0

Cambrex Announces Strategic Agreement with Lilly to Support Biotech Collaborator Manufacturing

BeiGene's flagship biologics manufacturing facility and clinical R&D center at the Princeton West Innovation Campus in Hopewell, N.J., is seen. (Photo: Business Wire)

BeiGene Opens Flagship U.S. Biologics Manufacturing and Clinical R&D Facility, Continues Global Expansion to Deliver Medicines to More Patients Around the World